Prevalence and rate of diagnosis of allergic rhinitis in Europe

By V. Bauchau, S. Durham. European Respiratory Journal, 2004

1,033 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. (2012, background): “Real-life studies are needed to confirm that the applicability of evidence obtained in randomized controlled trials (RCTs) translates into daily practice settings.72 Pragmatic randomized trials have found that the guideline-based management of AR is more effective than free treatment choice.56 Nonet”
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. (2010, methodology): “However, studies using the ARIA classification show that over 50% of patients sensitized to pollen suffer from PER (62, 67) and that, in the general population, a large number of patients sensitized to HDMs have mild IAR (62).”
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * (2008, methodology): “However, studies using the ARIA classification show that over 50% of patients sensitized to pollen suffer from PER (62, 67) and that, in the general population, a large number of patients sensitized to HDMs have mild IAR (62).”
Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine (2005, neutral): “At least one in five adults in Western Europe are estimated to have AR (Bauchau and Durham 2004), and its well-known nasal and eye symptoms can be severe enough to have a substantial negative impact on daily activities and sleep, with resulting impairment of quality of life (QoL) similar to that…”